|
|
Thursday, December 15, 2005
Optimer Pharmaceuticals Announces Funding
San Diego-based Optimer Pharmaceuticals said that it has raised $34.2M in two rounds of venture funding. The latest funding of $22.2M, closed November 30th, and included investments from ProQuest Investments, Lurie Investments, BB Biotech Ventures, SB Life Science Ventures, UOB JAIC Venture Bio Investments, as well as China Development Industrial Bank, ESun Bank Group, Fubon Financial Holding Venture, Global Strategic Investments, Oriental Union Chemical Corp., and Taiwan Global BioFund. The company also disclosed a Series C financing round of $12M from Par Pharmaceutical in April of 2005. Optimer is developing a narrow spectrum antibiotic in the biopharmaceuticals area.
posted on Thursday, December 15, 2005 (Link to more information)
|
 RSS
 Email
Previous news:
Tuesday, October 14, 2008
Monday, October 13, 2008
Friday, October 10, 2008
Thursday, October 9, 2008
Wednesday, October 8, 2008
|
